Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness

Chi Phuong Nguyen1,2,3, Maarten Uyttenboogaart4,5, Willemijn J Maas2,4

  • 1Department of Operations, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands p.nguyen@umcg.nl.

BMJ Open
|March 29, 2025
PubMed

Insights

The drive-the-doctor (DD) paradigm for large vessel occlusion (LVO) stroke is cost-effective. This model, with an interventionalist traveling to primary stroke centers, offers improved outcomes and is a promising evolution for stroke networks.

Area of Science:

  • Neuroscience and Neurology
  • Health Economics and Outcomes Research

Background:

  • The drive-the-doctor (DD) paradigm involves interventionalists traveling from comprehensive stroke centers (CSCs) to primary stroke centers (PSCs) for endovascular thrombectomy (EVT) in acute ischemic stroke due to large vessel occlusion (LVO).
  • This model aims to reduce delays in treatment initiation and improve recanalization times compared to the drip-and-ship (DS) paradigm.

Purpose of the Study:

  • To analyze the cost-effectiveness of the DD paradigm compared to the DS paradigm for LVO patients in the northern Netherlands.
  • To identify the optimal DD strategy considering variations in the number of upgraded PSCs and transportation modalities.

Main Methods:

  • Economic evaluation using a simulation model, decision tree, and Markov model.
  • Analysis of a hypothetical cohort of 100,000 LVO patients (average age 70) over a 15-year horizon from a Dutch healthcare provider perspective.
  • Testing DD paradigms with one or two upgraded PSCs, assessing transportation by car, ambulance, and helicopter, and using an ICER threshold of €50,000.

Main Results:

  • The DD paradigm utilizing car transport and two upgraded PSCs emerged as the optimal strategy, yielding the lowest incremental cost-effectiveness ratio (ICER).
  • This optimal strategy resulted in an additional 0.13 quality-adjusted life years (QALYs) at an incremental cost of €2367, with an ICER of €18,306.
  • Probabilistic sensitivity analyses indicated a 72% preference for the DD paradigm with two PSCs using car transport.

Conclusions:

  • The DD paradigm is a cost-effective approach for managing LVO patients.
  • This model represents a promising advancement for optimizing regional stroke networks and improving patient outcomes.
Abstract